| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 02/27/2013 | CN101632740B Chinese medicinal composition for regulating blood fat and improving sleeping and preparation method thereof |
| 02/27/2013 | CN101622229B Novel pyrrole derivative having ureido group and aminocarbonyl group as substituents |
| 02/27/2013 | CN101553474B Imidazolone and imidazolidinone derivatives as 11b-HSD1 inhibitors for diabetes |
| 02/27/2013 | CN101254242B Applications of Chinese medicinal composition for preparing inhibition angiotensin II receptor |
| 02/27/2013 | CN101010102B Composition comprising non-oxidizable fatty acid analogoues and plant and/or fish oils |
| 02/26/2013 | US8383683 Pharmaceutical use of substituted amides |
| 02/26/2013 | US8383680 Composition comprising free amino acids |
| 02/26/2013 | US8383667 Forms of [R-(R*,R*)]-2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid magnesium |
| 02/26/2013 | US8383647 Quinoline derivative |
| 02/26/2013 | US8383634 Methods of treatment using heteroaryl compounds and compositions thereof |
| 02/26/2013 | US8383628 Pyridyl derivatives and their use as therapeutic agents |
| 02/26/2013 | US8383622 Nitrogen-containing heterocyclic derivative having 11β-hydroxysteroid dehydrogenase type I inhibitory activity |
| 02/26/2013 | US8383178 Treating fish oils with certain amines/amides to reduce oxidation |
| 02/26/2013 | CA2632013C Adenovirus 36 e4 orf 1 gene and protein and their uses |
| 02/26/2013 | CA2440775C The nk1 fragment of hepatocyte growth factor/scatter factor (hgf/sf) and variants thereof, and their use |
| 02/26/2013 | CA2389644C A novel polypeptide hormone phosphatonin |
| 02/21/2013 | WO2013025984A2 Cannabinoid receptor treatments |
| 02/21/2013 | WO2013025202A1 Nutritional compositions comprising a soluble viscous fiber and a polyphenol-containing plant extract |
| 02/21/2013 | WO2013025201A1 Method of transforming a meal |
| 02/21/2013 | WO2013025073A2 Composition for preventing or treating diabetes complications containing quamoclit pennata extract |
| 02/21/2013 | WO2013024968A1 Novel compound isolated from quamoclit, and composition for preventing or treating diabetes containing the compound as an active ingredient |
| 02/21/2013 | WO2013024950A1 Anti-obesity composition including defatted silkworm pupa hydrolysate and method for preparing same |
| 02/21/2013 | WO2013024312A1 A pharmaceutical composition for the treatment of stem cells |
| 02/21/2013 | WO2013023563A1 Use of potassium piperonyl pentadienoate for lowering blood lipid |
| 02/21/2013 | WO2013006451A3 Macrocyclic insulin-degrading enzyme (ide) inhibitors and uses thereof |
| 02/21/2013 | WO2013003449A3 Methods of treatment with glp-1 receptor agonists |
| 02/21/2013 | WO2013000895A9 Dha and epa in the reduction of oxidative stress |
| 02/21/2013 | WO2012166614A9 Thiocarbamate and sulfonamide hydroxamate inhibitors of insulin-degrading enzyme |
| 02/21/2013 | WO2012156296A8 Pharmaceutical combination for use in inducing weight loss in diabetes type 2 patients or/and for preventing weight gain in diabetes type 2 patients |
| 02/21/2013 | WO2012134231A3 Benzamide derivative as cannabinoid receptor (cb1) antagonist |
| 02/21/2013 | US20130046020 Eicosapentaenoic acid concentrate |
| 02/21/2013 | US20130046016 Method for lowering cholesterol |
| 02/21/2013 | US20130046013 Salicylate fatty acid derivatives |
| 02/21/2013 | US20130046007 Selective reduction of allelic variants |
| 02/21/2013 | US20130046006 Inhibitors of fam3b gene, inhibitor compositions, inhibiting methods and applications of inhibitors in preparing pharmaceuticals |
| 02/21/2013 | US20130045994 Pyridine derivative |
| 02/21/2013 | US20130045990 Novel 1,2,3,4-tetrahydroquinoline derivative useful for the treatment of diabetes |
| 02/21/2013 | US20130045987 Novel methods of use of tetrahydroberberine (thb) |
| 02/21/2013 | US20130045986 Novel compounds as modulators of gpr-119 |
| 02/21/2013 | US20130045978 Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme |
| 02/21/2013 | US20130045964 Mandelamide heterocyclic compounds |
| 02/21/2013 | US20130045963 Cyclohexyl Azetidine Derivatives as JAK Inhibitors |
| 02/21/2013 | US20130045950 Phosphonate Compounds |
| 02/21/2013 | US20130045934 Extraction method using ultra fine bubbles and liquid extracts obtained thereof |
| 02/21/2013 | US20130045916 Treatment of type 2 diabetes, metabolic syndrome, myocardial injury and neurodegeneration with humanin and analogs thereof |
| 02/21/2013 | US20130045915 Method for weight loss and ketogenic compositions |
| 02/21/2013 | US20130045914 Biaryl spiroaminooxazoline analogues as alpha2c adrenergic receptor modulators |
| 02/21/2013 | US20130045289 Composition for promoting the activity of peroxisome proliferator-activated receptor-delta |
| 02/21/2013 | US20130045266 Method for preparing polymeric biomaterials having immobilized drug delivery system comprising bioactive molecules loaded particle carrier |
| 02/21/2013 | US20130045218 Fc receptor binding proteins |
| 02/21/2013 | US20130045213 Antibody therapy for modulating function of intestinal receptors and methods of treating diabetes and obesity |
| 02/21/2013 | US20130045186 Method of Detecting and/or Identifying Adeno-Associated Virus (AAV) Sequences and Isolating Novel Sequences Identified Thereby |
| 02/21/2013 | US20130045183 Boswellia oil, its fractions and compositions for enhancing brain function |
| 02/21/2013 | US20130045165 4-fluoro-4-arylpiperdin-1-yl derivatives as mu opioid function moderators |
| 02/21/2013 | US20130045164 Amyloid imaging as a surrogate marker for efficacy of anti-amyloid therapies |
| 02/21/2013 | CA2845496A1 Novel compound isolated from quamoclit, and composition for preventing or treating diabetes containing the compound as an active ingredient |
| 02/21/2013 | CA2845284A1 Substituted heterocyclic amine compounds as cholesteryl ester-transfer protein (cetp) inhibitors |
| 02/21/2013 | CA2844823A1 Method of transforming a meal |
| 02/21/2013 | CA2842926A1 Nutritional compositions comprising a soluble viscous fiber and a polyphenol-containing plant extract |
| 02/20/2013 | EP2559455A1 Heteroaryl derivatives as DGAT1 inhibitors |
| 02/20/2013 | EP2558500A1 Proteins that bind pi16 and uses thereof |
| 02/20/2013 | EP2558497A2 Human fgf receptor and beta-klotho binding proteins |
| 02/20/2013 | EP2558464A1 Azacyclic spiroderivatives as hsl inhibitors |
| 02/20/2013 | EP2558463A1 Fused derivatives as i3 inhibitors |
| 02/20/2013 | EP2558461A1 Novel glucokinase activators and methods of using same |
| 02/20/2013 | EP2558449A1 Novel 3,3-dimethyl tetrahydroquinoline derivatives |
| 02/20/2013 | EP2558440A1 Process for the production of polymorph form i of agomelatine |
| 02/20/2013 | EP2558125A2 Treating disorders associated with il-20 receptor-mediated signaling pathway by blocking il-20 receptor activity |
| 02/20/2013 | EP2558115A2 Methods for treating metabolic disorders using fgf |
| 02/20/2013 | EP2558105A2 Method of treating obesity using antioxidant inflammation modulators |
| 02/20/2013 | EP2557920A1 Methods for treating glucose metabolic disorders |
| 02/20/2013 | CN102939290A 2,3 dihydro-1h-inden-1-yl- 2,7-diazaspiro [3.6] nonane derivatives and their use as antagonists or inverse agonists of the ghrelin receptor |
| 02/20/2013 | CN102939283A Indazole compounds useful as ketohexokinase inhibitors |
| 02/20/2013 | CN102939089A Method of treating obesity using antioxidant inflammation modulators |
| 02/20/2013 | CN102939087A Novel indazole derivative or salt thereof, manufacturing intermediate therefor, antioxidant using same, and use for an indazole derivative or salt thereof |
| 02/20/2013 | CN102936561A Health white spirit |
| 02/20/2013 | CN102936560A Health-care yellow wine |
| 02/20/2013 | CN102936547A Healthcare port wine |
| 02/20/2013 | CN102936546A Health-care wine |
| 02/20/2013 | CN102936544A Healthcare beer |
| 02/20/2013 | CN102935231A Treatments using citrulline |
| 02/20/2013 | CN102935222A Application of ferric iron ferriporphyrin compound in preparation of anti-type-2 diabetes drug |
| 02/20/2013 | CN102935186A Healthcare tea for preventing diabetes mellitus |
| 02/20/2013 | CN102935152A Traditional Chinese medicine composition for treating hyperlipidaemia as well as preparation method and application thereof |
| 02/20/2013 | CN102935151A Medicine composition for protecting liver and lowering transaminase and preparation method and application thereof |
| 02/20/2013 | CN102935116A Pharmaceutical compositions or health care product having blood sugar reduction effect |
| 02/20/2013 | CN102935109A Compound crossostephium chinense tablet |
| 02/20/2013 | CN102935103A Preparation method for effervescent tablet containing pueraria mirifica flavone |
| 02/20/2013 | CN102935102A Method for simultaneously producing honeysuckle flower distillate and various active substances |
| 02/20/2013 | CN102935099A Extractive capable of reducing insulin resistance as well as preparation method and application thereof |
| 02/20/2013 | CN102935094A Composite for diabetes |
| 02/20/2013 | CN102935092A Novel lactobacilli and composition thereof, and application thereof in preparing medicines used for ameliorating diabetes and complications thereof |
| 02/20/2013 | CN102935087A Compound electrolyte injection composition and preparation method thereof |
| 02/20/2013 | CN102935086A Calcium tablet |
| 02/20/2013 | CN102935081A Dipeptidyl peptidase inhibitors for treating diabetis |
| 02/20/2013 | CN102935077A Bionic lovastatin nano-structured lipid carrier and preparation method thereof |
| 02/20/2013 | CN102935076A Capsule containing atorvastatin sodium and preparation method thereof |
| 02/20/2013 | CN102935073A Glimepiride dispersible tablet and preparation method thereof |
| 02/20/2013 | CN102934830A Health-care cola |
| 02/20/2013 | CN102934815A Donkey meat sausage |